Skip to Main content Skip to Navigation
Journal articles

First-line Nivolumab + Ipilimumab + Chemo in Patients With Advanced NSCLC and Brain Metastases: Results From CheckMate 9LA

Document type :
Journal articles
Complete list of metadata

https://www.hal.inserm.fr/inserm-03540850
Contributor : Elizabeth Bernardo Connect in order to contact the contributor
Submitted on : Monday, January 24, 2022 - 11:42:47 AM
Last modification on : Monday, September 5, 2022 - 1:50:06 PM

Links full text

Identifiers

Citation

D. Carbone, T. Ciuleanu, M. Cobo, M. Schenker, B. Zurawski, et al.. First-line Nivolumab + Ipilimumab + Chemo in Patients With Advanced NSCLC and Brain Metastases: Results From CheckMate 9LA. Journal of Thoracic Oncology, Lippincott, Williams & Wilkins, 2021, 16 (10), pp.S862. ⟨10.1016/j.jtho.2021.08.061⟩. ⟨inserm-03540850⟩

Share

Metrics

Record views

10